Medical research

Experimental drug delivers one-two punch to vision loss

In studies with lab-grown human cells and in mice, Johns Hopkins Medicine researchers have found that an experimental drug may be twice as good at fighting vision loss as previously thought.

Medical research

Researcher seeks early detection to forestall glaucoma's ravages

Glaucoma is the leading cause of blindness in the U.S. and worldwide. More than 3 million Americans suffer from the eye disease. If caught and treated early, its progression can be significantly slowed, but the disease often ...

Medical economics

Older patients with vision loss have higher hospital use, costs

(HealthDay)—Hospitalized Medicare beneficiaries with vision loss experience longer mean length of stay, higher readmission rates, and higher costs during hospitalization and postdischarge, according to a study published ...

Ophthalmology

Contact lens-based antihistamine delivery effective

(HealthDay)—A contact lens (CL)-based drug delivery system is effective for therapeutic delivery of the antihistamine ketotifen, according to a study published online March 19 in Cornea.

Neuroscience

What is the best sense? Scientists are still battling it out

If there is one thing Twitter has taught us, it's that the world loves a question that sounds stupid, but actually has a profound and interesting answer. For instance, what would happen if the world suddenly turned into blueberries, ...

Genetics

With single gene insertion, blind mice regain sight

It was surprisingly simple. University of California, Berkeley, scientists inserted a gene for a green-light receptor into the eyes of blind mice and, a month later, they were navigating around obstacles as easily as mice ...

page 2 from 23